Navigation Links
Tobira Therapeutics Inc. Announces Senior Management Team
Date:6/30/2008

- Senior management team possessing over 130 years of cumulative expertise

-

PRINCETON, N.J. and SAN DIEGO, June 30 /PRNewswire/ -- Tobira Therapeutics Inc., a clinical stage biotechnology company committed to the research and product discovery against life-threatening and life-altering infectious diseases, today announced the organization of the company's senior management team. Tobira Therapeutics has been led since its inception in 2006 by James Sapirstein, RPh, MBA as Chief Executive Officer and President. Joining James is Sandra Palleja, MD, Executive Vice-President and Chief Medical Officer, Angeline Shashlo, RPh, Senior Vice-President Regulatory Affairs and Quality Assurance, and Jay Rheingold, PhD, Vice-President Chemistry Manufacturing and Controls. These additions continue to build the management team with world-class pharmaceutical development experts. "With this senior management team Tobira Therapeutics has more than 130 years of combined pharmaceutical experience, with the majority focused in biotech companies or HIV compounds. We are perfectly positioned to bring novel molecules to market that will play an important role in the treatment of HIV infection".

Dr. Palleja is the Chief Medical Officer, responsible for the overall clinical development of the Tobira Therapeutics portfolio. Sandra joined Tobira from Shionogi USA, where she lead numerous clinical programs as Vice President of Clinical Development in several therapeutic categories including an HIV joint venture with GSK. Prior to her years at Shionogi, Sandra gained additional experience from both Triangle Pharmaceutics and Hoffman-LaRoche, where she helped develop a variety of antivirals for HIV and hepatitis including FTC, DAPD, ganciclovir, and saquinavir. Prior to her career in industry, she was the Director of the Infectious Diseases Clinic at St. Vincent's Hospital and Medical Center of New York City during the mid to late 90's. Pri
'/>"/>

SOURCE Tobira Therapeutics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Duska Therapeutics Obtains Standard & Poors Listing
2. Spectral announces continuing support for the combination of EAA(TM) and anti-endotoxin therapeutics
3. FDA Approves Quark IND for DGFi, an siRNA Therapeutic Based on Silence Therapeutics Unique Proprietary Chemistry
4. Sirion Therapeutics Announces FDA Approval of Durezol(TM) for Treatment of Postoperative Ocular Inflammation and Pain
5. Commercial Launch of Lexiscan(TM) (Regadenoson) Injection Triggers $10 Million Milestone Payment from TPG-Axon Capital to CV Therapeutics
6. Barrier Therapeutics to Merge Into Stiefel Laboratories
7. TorreyPines Therapeutics to Present Tezampanel Phase IIb Clinical Data for Acute Migraine at 50th Annual Scientific Meeting of the American Headache Society
8. Shareholders Approve All Matters Proposed by Cell Therapeutics, Inc. at Special Meeting in Lieu of Annual Meeting of Shareholders
9. Halozyme Therapeutics to Present at the Jefferies 2nd Annual Healthcare Conference
10. Cell Therapeutics, Inc. Repays $11.0 million Balance of 2008 Convertible Debt
11. Cell Therapeutics, Inc. Special Meeting in Lieu of Annual Meeting of Shareholders Scheduled for Thursday, June 19, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2008)...28 ExonHit Therapeutics ...scovery company, announces today,the availability...use models,of human disease. These SpliceArray(TM... their therapeutic target discovery and validation...ofiling analysis, we identify novel,transcripts c...
(Date:11/27/2008)... On Monday, December 1, ...pean/5:30 a.m. Pacific, members of,Cell Therapeut...t team will,host a conference call to discuss the...e, California to jointly market and develop Zevali...ay, December 1, 8:30 a.m. Eastern/2:30 p.m. Ce...
(Date:11/27/2008)...zerland, November 27 Helsinn Healt...s signed a partnering agreement with,Zealand Phar...ation of,ZP1846, a GLP-2 (glucagon-like peptide-2...treat chemotherapy-induced diarrhea (CID), a debil...ancer treatment with a range of,chemotherapies. ,...
(Date:11/26/2008)...wins increase 400% to $16 million in third quarter...nclude $1.9 million non-cash goodwill impairment c...FirstCall/ -- Encorium Group, Inc. (Nasdaq: ENC...ch organization (CRO) conducting studies in over 3...aceutical and biotechnology companies, today annou...
Breaking Biology Technology:ExonHit Launches Mouse Genome SpliceArray(TM) for use in Human Disease Modeling Studies 2ExonHit Launches Mouse Genome SpliceArray(TM) for use in Human Disease Modeling Studies 3Helsinn Healthcare and Zealand Pharma Sign a Partnering Agreement for ZP1846, a Novel GLP-2 Agonist 2Helsinn Healthcare and Zealand Pharma Sign a Partnering Agreement for ZP1846, a Novel GLP-2 Agonist 3Helsinn Healthcare and Zealand Pharma Sign a Partnering Agreement for ZP1846, a Novel GLP-2 Agonist 4Helsinn Healthcare and Zealand Pharma Sign a Partnering Agreement for ZP1846, a Novel GLP-2 Agonist 5Helsinn Healthcare and Zealand Pharma Sign a Partnering Agreement for ZP1846, a Novel GLP-2 Agonist 6Encorium Reports Third Quarter 2008 Financial Results 2Encorium Reports Third Quarter 2008 Financial Results 3Encorium Reports Third Quarter 2008 Financial Results 4Encorium Reports Third Quarter 2008 Financial Results 5Encorium Reports Third Quarter 2008 Financial Results 6Encorium Reports Third Quarter 2008 Financial Results 7Encorium Reports Third Quarter 2008 Financial Results 8Encorium Reports Third Quarter 2008 Financial Results 9
... in the Madison economy since 1906 will be moving ...rb in May. , ,According to Atlantic Business Chro...th. The announcement came as a surprise to many. ,...et the chance to try to work with [Rayovac], said ...ave Cieslewicz. Keeping local businesses is import...
...,With deregulation of the retail electric utility ..., it appears to be a time to return to regulated u...egislators should revisit the original text for th...nt for its future direction. As Wisconsins positio...2 in the Priorities section, In meeting energy dem...
...y job market these days is an exercise in faith. E...ng hope that things are truly turning around. , ,... out of work. More and more often, when we tell th... I saw that job (on Craigs List or ChicWIT or ...ursuing it. It looks like a no-win situation." , ...
...ference in San Francisco is still seeping out (eve...news made the Wall Street Journal), the overall se...sm. , ,Remember that there are at least 15 IPOs q...cted to be in the $150 million range) and the afte...nitored. The last time the IPO window was open in ...
Other Biology Technology:Rayovac to Relocate Headquarters 2Wisconsin Should Create, like Renewables, an Energy Efficient Portfolio 2Wisconsin Should Create, like Renewables, an Energy Efficient Portfolio 3Wisconsin Should Create, like Renewables, an Energy Efficient Portfolio 4Pity the Midwest Technology Sales Guy 2Pity the Midwest Technology Sales Guy 3Pity the Midwest Technology Sales Guy 4Pity the Midwest Technology Sales Guy 52003 Biotech Results 2
(Date:11/27/2008)...on genetic polymorphisms induce major differentiat...ion, according to a paper published November 28 in...rnational team of researchers, led by Karsten Suhr...ith metabolomics, identifying genetic variants in ...ting differences in metabolic capacity can affect ...
(Date:11/27/2008)...entists at St. Jude Children,s Research Hospital h...cancer cells of children with acute lymphoblastic ...ers a pathway to designing treatments for ALL rela...e most common childhood cancer, ALL affects thousa...hough more than 80 percent of ALL cases are cured,...
(Date:11/26/2008)... Wildlife Conservation Society, the Government of ...create a new national park to help protect the wor...rilla. , The park now forms part of an important...s River National Park, safeguarding an estimated 1...lationalong with other rare species. Trans-boundar...
(Date:11/26/2008)...er shapes societies, but it is a factor only just ..., The Norwegian professor, writer and film maker...en, argues that water has played a unique and fund... history. Speaking at a European Science Foundatio...proposed that social scientists and historians hav...
Breaking Biology News(10 mins):Study identifies genetic variants giving rise to differences in metabolism 2St. Jude identifies genomic causes of a certain type of leukemia relapse 2St. Jude identifies genomic causes of a certain type of leukemia relapse 3New national park protects world's rarest gorilla 2New national park protects world's rarest gorilla 3Using water to understand human society, from the industrial revolution to global trade 2Using water to understand human society, from the industrial revolution to global trade 3Study Shows Physician Judgment is Important in Reducing Rate of RSV Related Hospitalizations Among High Risk Infants 1965 1Study Shows Physician Judgment is Important in Reducing Rate of RSV Related Hospitalizations Among High Risk Infants 1965 2Study Shows Physician Judgment is Important in Reducing Rate of RSV Related Hospitalizations Among High Risk Infants 1965 3Federal Health Plan for Children Still Leaves Needs Unmet 18376 1Federal Health Plan for Children Still Leaves Needs Unmet 18376 2Autistic Kids More Likely to Have Parents With Mental Illness 18374 1Autistic Kids More Likely to Have Parents With Mental Illness 18374 2Major League Baseball Hall of Famer Don Sutton Helps Kidney Cancer Patients Stay In The Game 28TM 29 18372 1Major League Baseball Hall of Famer Don Sutton Helps Kidney Cancer Patients Stay In The Game 28TM 29 18372 2Major League Baseball Hall of Famer Don Sutton Helps Kidney Cancer Patients Stay In The Game 28TM 29 18372 3Major League Baseball Hall of Famer Don Sutton Helps Kidney Cancer Patients Stay In The Game 28TM 29 18372 4Major League Baseball Hall of Famer Don Sutton Helps Kidney Cancer Patients Stay In The Game 28TM 29 18372 5
... Environmental and genetic factors lead to neural ...1 in 20 of every spontaneous abortion. One cause o... neural tube to migrate to the middle of the devel...ue of Nature is the first to report on the molecul...correct local within the developing neural tube of...
... Trees, particularly those with deep roots, contri...sts thought, according to a new study by biologist...rnia, Berkeley. , While scientists studying global...tion in removing carbon dioxide from the atmospher... have assumed a simple model of plants sucking wat...
... Almost three metres of tightly-coiled DNA strands... strands unwind and unfold and then re-package int... what happens if this process becomes entangled? ,...ivision is the job of special enzymes called topoi...er than previously thought, says U of T research. ...
... The cell is understood to be highly organized, wi...olecular motors shuttling components around. Resea...d Urbana-Champaign campuses now offer the first im...tion and transport within the cell nucleus. , Gen...al region of the nucleus, while inactive genes are...
Other Biology News:Deep-rooted plants have much greater impact on climate than experts thought 2Deep-rooted plants have much greater impact on climate than experts thought 3Deep-rooted plants have much greater impact on climate than experts thought 4Researchers unravel DNA tangles and enzyme seamstresses 2Movement of chromosome in nucleus visualized 2Movement of chromosome in nucleus visualized 3
Attofluor cell chamber from Molecular Probes (Invitrogen)
Rabbit polyclonal antibody to NMDA NR2B [Tyr1336]
ImmunoPure Plus Immobilized Protein G, , , , Support: Cross-linked 6%, beaded agarose , Capacity: > 20 mg human IgG/ml of gel
Mouse monoclonal antibody to FMN2 - formin 2
Biology Products: